<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">

Champions Oncology Reports Quarterly Revenue of $12.8 Million

Mar 16, 2023 5:10:07 PM / by Champions Oncology

Hackensack, NJ - March 15, 2023 Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced its financial results for its third quarter of fiscal 2023, ended January 31, 2023.

Read More →